Source
37 articles citing this source
JWST observations of super-Earth L 98-59 d reveal a sulfur-dominated atmosphere sustained by a perpetual magma ocean, a combination that fits no existing planetary category and may define a new class of exoplanet.
A failed control experiment led Cambridge chemists to discover a metal-free, LED-driven method for modifying drug molecules at positions previously considered unreachable, reversing the selectivity rules established by Friedel and Crafts in 1877.
The second International AI Safety Report, led by Yoshua Bengio with 100+ experts, warns AI capabilities are outpacing safety measures as frontier models show signs of deception.
A Nature paper describes INSTALL, a gene editing platform using circular single-stranded DNA to insert therapeutic genes without triggering fatal immune responses, keeping mice healthy at doses where conventional DNA proved lethal.
Paleontologists report paired discoveries from China that rewrite the early chapter of bony fish evolution and, by extension, the evolutionary lineage leading to all living vertebrates including humans.
Japan's health ministry has conditionally approved two iPS cell-derived drugs, marking the first time regenerative medicines built from induced pluripotent stem cells will reach patients commercially.
Researchers at Delft and CSIC Madrid have demonstrated single-shot parity readout of Majorana qubits in Nature, solving a decades-long measurement problem.
A Washington University team showed a p-tau217 blood test can estimate Alzheimer's symptom onset within 3-4 years, potentially transforming early intervention and clinical trials.
Microsoft Research published a Nature paper showing ordinary borosilicate glass can store 4.8 TB of data for over 10,000 years, extending its Project Silica archival storage technology to everyday materials.
A second-generation Pro-Active Genetics system spreads via bacterial conjugation to disable resistance genes on plasmids, working even inside biofilms.
An 863-person Nature study identifies the SCAN brain network as the core driver of Parkinson's, with all four major treatments working by reducing its abnormal hyperconnectivity.
The FDA's new Plausible Mechanism Pathway enables approval of one-patient gene editing therapies without traditional clinical trials, inspired by the first personalized CRISPR cure for an infant with a fatal metabolic disorder — but ethicists warn of a regulatory Pandora's box.